By Claire Guzior
on May 26, 2023
The FDA approved the drug semaglutide for those suffering from obesity, diabetes, and other weight-related illnesses. Since its approval, semaglutide has faced worldwide popularity — resulting in supply shortages.
By Thea Le Fevre
on May 17, 2023
The US Food and Drug Administration (FDA) recently warned the public about online sales of Apetamin — an unapproved drug produced internationally and sold worldwide. Read more to understand why this drug is potentially harmful to consumers.
on May 11, 2023
LegitScript vets CBD manufacturer's products for accurate and transparent labeling in line with regulatory bodies like the US Food and Drug Administration (FDA). Read further to understand what LegitScript’s CBD Certification does to protect consumers.
on May 04, 2023
LegitScript’s Associate General Counsel, Gerard Olson, dives deep into the regulatory landscape of vaping and tobacco in our Deep Dive Webinar Series. Read this recap of the webinar to understand who regulates tobacco and vaping products, and what it takes to get a tobacco product to market. Then, watch the full webinar at the button below.
on April 21, 2023
Cameron D’Ambrosi, host of the State of Identity podcast, sits down with LegitScript CEO Scott Roth to discuss tactics in identifying whether a company is trustworthy, and the future of the online risk and compliance space. Read an abridged Q&A of the conversation below for key takeaways, or listen to the full interview.